Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900022610Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of milrinone in intraoperative bleeding (2 arms), sponsored by Huadong Hospital, Fudan University. Primary endpoints: Intraoperative blood loss, Autologous blood transfusion and 1 more. Planned start May 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900022610.